NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Nephros, Inc. (NEPH) Stock Analysis

Nephros, Inc. (NEPH) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

NEPH

$3.59

+$0.07 (+1.99%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NEPH with… →

NEPH Key Statistics

As of Oct 21, 2026
Trading
Open
$3.58
Previous Close
$3.52
Day's Range
3.53–3.71
52-Week Range
2.66–6.42
Volume
14.21K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.64
Valuation
Market Cap
$38.99M
P/E Ratio
23.93
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.10
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.88
EPS (ttm)Profit attributable to each share over the last twelve months.
0.15
Financials (FY)
Revenue (FY)
$18.79M+32.67%
Net Income (FY)
$1.19M+1,513.51%
Profit marginThe share of revenue left as profit after all costs and taxes.
8.38%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
10.86M
1-Year Return
−25.98%
Dividend and dates
Earnings Date
November 5, 2026
Avg Volume
31.33K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, NEPH closed at $3.59, −25.98% over 1 year.

Nephros, Inc. (NEPH) has a market capitalization of $38.99M.

In fiscal 2025, NEPH reported revenue of $18.79M.

NEPH Stock Return by Calendar Year

Nephros, Inc. (NEPH) 10-year return: what $10,000 became

1 year
$10,000 $7,402
−25.98%
5 years
$10,000 $4,787
−52.13%
10 years
$10,000 $12,088
+20.88%

If you had invested $10,000 in Nephros, Inc. (NEPH) 10 years ago, at the close on October 21, 2016, it would have been worth $12,088 at the close on October 21, 2026: +20.88% in total, +1.91% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−26.43%
2025+231.97%
2024−57.51%
2023+198.28%
2022−80.34%
2021−31.24%
2020−13.77%
2019+93.96%
2018+26.67%
2017+21.62%
2016 (partial year)+27.59%

As of October 21, 2026.

NEPH Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$18.79M$1.19M6.4%
2024$14.16M$74.00K0.5%
2023$14.24M−$1.58M−11.1%
2022$9.98M−$7.38M−74.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$18.79M$11.63M$1.15M$1.19M6.4%
2024$14.16M$8.72M$6.00K$74.00K0.5%
2023$14.24M$8.41M−$1.59M−$1.58M−11.1%
2022$9.98M$4.73M−$4.34M−$7.38M−74.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NEPH Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricNEPHMedical Instruments & Supplies medianvs median
P/E23.9331.1923% below
P/S ratio1.882.6028% below
Profit margin8.38%1.62%6.8 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Nephros, Inc. (NEPH) at $38.99M. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 36 employees.

The 52-week range on file runs from $2.66 to $6.42. NEPH last closed at $3.59 on October 21, 2026. That is +$0.07 (+1.99%) against the previous close. The latest close sits 34.96% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $18.79M. That is +32.67% against the prior fiscal year, when revenue was $14.16M. Net income for the same year was $1.19M. That is +1,513.51% against the prior fiscal year. The reported profit margin is 8.38%. That is 6.8 percentage points above the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 0.15.

Across the 4 fiscal years on file, revenue moves from $9.98M in 2022 to $18.79M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

NEPH trades at a trailing price-to-earnings ratio of 23.93. That is 23.28% below the Medical Instruments & Supplies median of 31.19. The forward P/E on file is 17.1. The price-to-sales ratio is 1.88. On price-to-sales that is 27.57% below the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −25.98%. Measured over 10 years, that is +1.91% a year compounded. Beta against the wider market is reported at 1.64. Annualized volatility over the trailing 10 years is 83.35%.

Growth & Income

The record shows no dividend for NEPH.

Across the complete calendar years on file, 2025 returned +231.97% and 2022 returned −80.34%. Of the 9 complete calendar years on file, 5 finished higher. So far in 2026 the total return is −26.43%.

Peer Comparison

Nephros, Inc. (NEPH) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Nephros, Inc. NEPH $38.99M 23.9
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Nephros, Inc. trades at a P/E of 23.9.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Nephros, Inc.

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Visit website →